Researchers have created an AI tool that uses CT imaging to predict the spread risk of oropharyngeal cancer, offering improved treatment stratification.
Key Details
- 1Developed and validated by Mass General Brigham and Dana-Farber Cancer Institute.
- 2AI tool predicts likelihood of lymph node extranodal extension (ENE) using CT scans.
- 3Tested on imaging data from 1,733 patients with oropharyngeal carcinoma.
- 4Integration of AI assessment improved risk stratification for survival and cancer spread.
- 5Could guide both escalation and de-escalation of treatment strategies.
- 6Published in Journal of Clinical Oncology (DOI: 10.1200/JCO-24-02679).
Why It Matters
This tool offers a noninvasive approach for more accurate prognosis and tailored therapies in head and neck cancer, potentially reducing unnecessary interventions and improving outcomes. It demonstrates a significant advance in leveraging imaging AI for complex cancer management decisions.
Source
EurekAlert
Related News
•EurekAlert
AI Model Accurately Predicts Recurrence After Barrett’s Esophagus Therapy
Researchers created an AI tool that predicts recurrence of Barrett’s esophagus following endoscopic eradication therapies with greater than 90% accuracy.
•EurekAlert
Hybrid AI Model Enhances Early Lung Cancer Detection on CT Scans
Researchers developed a hybrid AI model that significantly improves early lung cancer detection from CT scans.
•EurekAlert
NIH Invests Additional $12.6M in USC-Led Imaging AI for Alzheimer's
NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.